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Background Obesity was recognized as in independent risk factor
for inﬂuenza during the 2009 H1N1 inﬂuenza pandemic.
Objectives We evaluated the association between body mass index
(BMI) and inﬂuenza-like illness (ILI) during two non-pandemic
inﬂuenza seasons (2003–2004 and 2004–2005) and during the spring
and fall waves of the 2009 H1N1 pandemic.
Methods Adults with severe (inpatient) and mild (outpatient) ILI
were compared to those without ILI using a case-cohort design. The
study was nested among those insured by a single health insurance
company, receiving care from a large multispecialty practice. Data
were collected from insurance claims and the electronic health
record. The primary exposure was obesity (BMI ≥ 300 kg/m
2).
Results Across three seasons, the crude and adjusted ORs for
obesity and severe ILI were 165 (95% CI 131, 208) and 123 (95%
CI 097, 157), respectively. An association was observed for those
aged 20–59 years (adjusted OR 192, 95% CI 126, 290), but not for
those 60 and older (adjusted OR 108, 95% CI 080, 146). The
adjusted ORs for obesity and severe ILI in 2003–2004, 2004–2005,
and during H1N1 were 114 (95% CI 080, 164), 124 (95% CI 086,
179), and 176 (95% CI 091, 342), respectively. Among those with
a Charlson Comorbidity Index score of zero, the adjusted ORs for
2003–2004, 2004–2005, and H1N1 were 160 (95% CI 093, 276),
143 (95% CI 080, 256), and 190 (95% CI 068, 527), respectively.
Conclusions Our results suggest a small to moderate association
between obesity and hospitalized ILI among adults.
Keywords BMI, inﬂuenza, obesity.
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Introduction
Early investigations of 2009 pandemic inﬂuenza A H1N1
(2009 H1N1) noted that severity of illness was associated
with obesity.
1–6 Subsequent analyses suggested an association
of obesity with both hospitalization and death from 2009
H1N1.
7–9 Before the 2009 H1N1 pandemic, however, obesity
was not recognized as an independent risk factor for
inﬂuenza in general and severe inﬂuenza in particular.
Two groups have recently examined the association
between body mass index (BMI) and inﬂuenza during
non-pandemic inﬂuenza seasons. Coleman and co-authors
conducted a case–control study of outpatient, laboratory-
conﬁrmed inﬂuenza during two typical ﬂu seasons (2007–2008
and 2008–2009) and the 2009 pandemic season.
10 They found
no differences in mean body mass index (BMI) between cases
and controls in each season. They interpreted their multivar-
iate modelasindicating noevidence ofan associationbetween
obesityandinﬂuenza,althoughtherewasevidence–albeitnot
statistically signiﬁcant – of increased odds of medically
attended inﬂuenza among at least the highest category of
BMI during the 2009 pandemic. Another group examined the
associationbetweenobesityandrespiratoryhospitalizationsin
Ontario, Canada.
11 These authors combined hospitalization
claims data with self-reported BMI from 12 inﬂuenza seasons
and found an association between obesity and hospitalized
respiratory conditions among patients with and without
recognizedrisk factorsforsevereinﬂuenzacomplications(i.e.,
chronic health conditions such as heart and respiratory
disease).
Given these conﬂicting data, we examined the association
between obesity and inﬂuenza-like illness (ILI) incidence and
severity among adults during two non-pandemic inﬂuenza
seasons (2003–2004 and 2004–2005) and during the spring
and fall waves of the 2009 H1N1 pandemic. We hypothesized
that obesity would be associated with increased risk for
hospitalized ILI during non-pandemic inﬂuenza seasons as
well as during pandemic H1N1.
Methods
Study population and data source
We compared individuals with mild (outpatient) and severe
(inpatient) ILI to those without ILI using a case-cohort
DOI:10.1111/irv.12156
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case deﬁnitions and individuals selected as a control may also
be a case.
12 We nested the study among individuals with
Harvard Pilgrim Health Care insurance receiving care from
Harvard Vanguard Medical Associates (HVMA), a large
multispecialty ambulatory practice group based in Eastern
Massachusetts. Cases, comorbidities, and outcomes were
identiﬁed using insurance claims codes and electronic health
record (EHR) data. We evaluated three study periods: two
regular inﬂuenza seasons (2003–2004 and 2004–2005) and
the pandemic H1N1 2009 season. The 2003–2004 season was
chosen due to its relative severity in comparison with other
recent seasons. The predominant inﬂuenza A strain during
the 2003–2004 season was H3N2, although there was co-
circulation of A(H1) and B. During the 2004–2005 season, A
(H3N2) was also the predominant strain, but more B isolates
were detected.
13 The two non-pandemic seasons were
deﬁned as October 1, 2003, to May 31, 2004, and October
1, 2004, to May 31, 2005. The H1N1 pandemic period was
deﬁned as April 1, 2009, to December 15, 2009.
The following inclusion criteria applied to each cohort
relative to the season’s start date: age ≥ 20 years, no history
of hospitalization in the prior year, no history of ILI in the
preceding month, and measured BMI in the EHR during the
study period or year preceding the start date. Pregnant
women and underweight subjects (BMI < 185 kg/m
2) were
excluded.
Source data on body mass index, race/ethnicity, and
temperature came from the electronic health record of the
study practice. The practice uses the Epic Care (Epic Systems,
Madison, WI, USA) electronic health record for all clinical
transactions including registration, vital sign records, labo-
ratory test ordering, laboratory test result tracking, and
prescriptions. Clinicians assign diagnosis codes for each visit
using dropdown menus. The dropdown menus are pre-
populated with the diagnosis codes used most frequently by
each practice, but clinicians have the freedom to select and
assign any diagnosis code. Diagnosis codes for case determi-
nation were drawn from patients’ insurance claims records.
Case identiﬁcation
Cases were identiﬁed on the basis of International Classiﬁ-
cation of Disease, 9th Revision, Clinical Modiﬁcation (ICD-
9) codes (Table 1) using a previously validated deﬁnition.
14–16
Cases required at least one code from Table 1; if the EHR
contained a measured temperature from the same encounter,
it had to be >378 degrees Celsius for the case to be counted.
Two types of ILI cases were identiﬁed: mild and severe ILI.
Mild ILI was based on diagnostic codes from outpatient visits
only, including emergency department visits. Severe ILI was
based on diagnostic codes from inpatient visits. Severe ILI is
the primary outcome of interest. Inpatient visits included all
inpatient stays, same-day hospital discharges, hospital trans-
fers, observation bed stays, and acute hospital care where the
Table 1. ICD-9 codes used to identify mild and severe cases of inﬂuenza-like illness (ILI)
7989 Viral infection, NEC 480 Viral pneumonia
7999 Viral infection, NOS 4808 Pneumonia due to virus NEC
460 Nasopharyngitis, acute 4809 Viral pneumonia unspeciﬁed
461 Sinusitis, acute 481 Pneumococcal pneumonia
462 Pharyngitis, acute 482 Other bacterial pneumonia
463 Tonsillitis, acute 4822 Pneumonia due to Haemophilus inﬂuenzae
464 Laryngitis and tracheitis 4823 Pneumonia due to Streptococcus
46401 Laryngitis, acute, with obstruction 4824 Staphylococcus pneumonia NOS
4641 Tracheitis, acute, without obstruction 48241 MSSA pneumonia
46411 Tracheitis, acute, with obstruction 48249 Other staphylococcus pneumonia
4642 Laryngotracheitis, acute, without obstruction 4829 Bacterial pneumonia unspeciﬁed
46421 Laryngotracheitis, acute, with obstruction 483 Pneumonia due to other speciﬁed organism
465 Acute upper respiratory infections of multiple or unspeciﬁed sites 4848 Pneumonia in other infectious disease
464.2 Laryngotracheitis, acute 485 Bronchopneumonia, organism NOS
4658 Infectious upper respiratory, multiple sites, acute NEC 486 Pneumonia, organism NOS
4659 Infectious upper respiratory, multiple sites, acute NOS 487 Inﬂuenza
466 Acute bronchitis and bronchiolitis 487.0 Inﬂuenza with pneumonia
466.0 Bronchitis, acute 4871 Inﬂuenza with respiratory manifestation NEC
4661 Bronchiolitis, acute 4878 Inﬂuenza with manifestation NEC
46619 Bronchiolitis, acute, due to other infectious organism 7841 Pain, throat
4789 Disease, upper respiratory NEC/NOS 7862 Cough
NOS, not otherwise speciﬁed; NEC, not elsewhere classiﬁed.
Cases had at least one of the respiratory codes listed, and a measured fever of at least 100F, an ICD-9 code of 7806 (fever), or no measured
temperature or ICD-9 code.
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outpatient visit meeting the mild ILI case deﬁnition and then
had an inpatient visit meeting the severe ILI deﬁnition
during the study period were classiﬁed as severe cases. If
there were multiple mild or multiple severe ILI visits, the case
date was assigned based on the ﬁrst such visit.
Control selection
We randomly selected four times the number of controls as
there were mild cases per cohort. These 4:1 controls were a
random sample of the eligible participants. There was no
matching of controls to cases on any factor.
Exposure variable
Body mass index was obtained from the vital signs informa-
tion in the EHR. We included values collected at any time
during the study period or the preceding 12 months. For
cases, we used BMI measured closest to the case date. For
controls, we used the BMI measured closest in time to the
season start date. It was acceptable to take height and weight
from different visits to calculate BMI, if necessary, as long as
both were within the deﬁned timeframe.
The primary exposure of interest was obesity, deﬁned as
BMI ≥ 300 kg/m
2 (WHO). We also examined weight cat-
egorized as overweight (BMI 250–299 kg/m
2). Normal
weight (BMI 185–249 kg/m
2) was the reference category.
Covariates
Charlson comorbidity index scores (Charlson scores)
17 were
calculated based on ICD-9 codes documented in the EHR
within 1 year of the season start date for the following
conditions: myocardial infarction, congestive heart disease,
peripheral vascular disorder, cerebrovascular disorder,
dementia, chronic pulmonary disease, rheumatologic disease,
peptic ulcer disease, mild liver disease, diabetes, diabetes with
chronic complications, hemiplegia or paraplegia, renal dis-
ease, malignancy including leukemia and lymphoma, mod-
erate or severe liver disease, metastatic solid tumor, and AIDS.
Statistical analysis
We computed the frequency and proportion of subjects
within BMI categories. We calculated odds ratios (OR), with
corresponding 95% conﬁdence intervals (CI), associating the
occurrence of severe or mild ILI with overweight and obesity,
relative to normal weight. We examined potential confound-
ers in binary analyses and by change in the OR. We used
multivariate logistic regression to adjust for likely confound-
ers. Analyses were performed using SAS version 93 (SAS
Institute, Inc., Cary, NC, USA).
This study was approved by the Harvard Pilgrim Health
Care Institute Human Studies Committee (IRB reference
number 222927). The work was supported in part by funding
from the Centers for Disease Control and Prevention.
Results
Across all three seasons, there were 471 cases of severe ILI
and 6127 cases of mild ILI. The median BMI was 278 among
people with severe ILI, 273 for people with mild ILI, and
269 for patients without ILI. For all seasons combined, the
crude OR for severe ILI among overweight and obese
patients combined (BMI ≥ 25) was 145 (95% CI 118, 178).
After adjusting for age, Charlson score, and sex, the OR for
BMI ≥ 25 and severe ILI was 110 (95% CI 089, 137). For
obese patients with BMI ≥ 30, the odds ratio for severe ILI
was 165 (95% CI 131, 208). After adjusting for age,
Charlson score, and sex, the OR for obesity and severe ILI
was 123 (95% CI 097, 157). The crude OR for overweight
and severe ILI was 129 (95% CI 102, 162); the adjusted OR
for overweight and severe ILI was 099 (95% CI 078, 126).
The characteristics of cases and controls, by season, are
compared in Table 2. Severe ILI cases were older compared
with mild ILI cases and controls, although they were
substantially younger during H1N1 (median 57 years) com-
pared with the two regular seasons (median 72 years). The
proportion of females among controls, mild cases, and severe
cases varied by season. Sixty-eight percent (68%) of the
hospitalized cases had a pneumonia-related diagnosis (i.e.,
general pneumonia ICD-9 code or organism-speciﬁc pneu-
monia code). By season, 79%, 57%, and 66% of severe cases
were pneumonia-related in 2003–2004, 2004–2005, and
H1N1, respectively.
While it appears that severe ILI cases had a higher
proportion of having received seasonal inﬂuenza vaccine
compared with mild ILI cases and controls, the vaccination
information is incomplete in this dataset because individuals
may receive inﬂuenza vaccine outside of their primary care
provider’s ofﬁce, and those doses would not be captured in
the EHR. We therefore cannot interpret or analyze vaccina-
tion status. Approximately two-thirds of individuals had
missing race information in the full dataset, and we therefore
cannot interpret these data.
To evaluate severe ILI among otherwise healthy adults, we
restricted the analysis to individuals with a Charlson score of
zero. Among those with no identiﬁed comorbidities, the
crude OR for obesity and severe ILI was 183 (95% CI 127,
265). After adjusting for age and sex, the OR was 155 (107,
225). The crude OR for overweight and severe ILI among
those with a Charlson score of zero was 133 (092, 192); the
adjusted OR was 107 (073, 155).
BMI and ILI by Inﬂuenza Season
Table 3 contains results from logistic regression models
examining the association between overweight and obesity
with severe and mild ILI, by inﬂuenza season. There is
evidence of a small association between obesity and severe ILI
in 2003–2004 (OR 114, 95% CI 080, 164) and 2004–2005
Obesity as a risk factor for severe ILI
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2009 H1N1 (OR 176, 95% CI 091, 342), although not
statistically signiﬁcant at the P < 005 level. There does not
appear to be an association between overweight and severe
ILI for any of the three study periods.
Our results suggest there may be a small association
between obesity and mild ILI in 2004–2005 (OR 126, 95%
CI 113, 140) and 2009 H1N1 (OR 122, 95% CI 105, 142).
The association between overweight and mild ILI is small or
close to null for both of those periods. Table 4 includes
results from the same analyses as above, restricted to
individuals with a Charlson score of zero. The results are
generally consistent, although the ORs are larger and the
conﬁdence intervals wider due to fewer cases.
BMI and ILI by Age Group
For 20- to 39-year-olds, the median BMI among severe cases
(n = 24), mild cases (n = 1575), and controls (n = 6256) was
268, 259, and 254, respectively. For 40- to 59-year-olds, the
median BMI among severe cases (n = 118), mild cases
(n = 2572), and controls (n = 13 046) was 294, 279, and
272, respectively. For those aged 60 and older, the median
BMI among severe cases (n = 329), mild cases (n = 1980),
and controls (n = 6626) was 274, 277, and 276. The
adjusted OR for those aged 20–59 years was 192 (95% CI
126, 290) and was 108 (95% CI 080, 146) for those 60 and
older. When we further stratiﬁed the younger age group
(Table 5), there appears to be an association that does not
achieve statistical signiﬁcance at the P < 005 level, between
obesity and severe ILI among 20- to 39-year-olds (OR 243,
Table 2. Characteristics of mild and severe cases of inﬂuenza-like
illness (ILI) and controls for three inﬂuenza seasons (2003–2004; 2004
–2005; 2009 H1N1) in Massachusetts
Severe ILI Mild ILI Controls
2003–2004 n = 202 n = 2194 n = 8929
Age–Mean  SD 68  16 52  18 51  15
Age–Median 72 52 51
BMI–Mean  SD 29  632 8  602 8  57
BMI–Median 28 27 27
No. (%) No. (%) No. (%)
Normal weight 58 (29) 745 (34) 3057 (34)
Overweight 71 (35) 757 (35) 3234 (36)
Obese 73 (36) 692 (32) 2638 (30)
Female 103 (51) 1514 (69) 5687 (64)
Charlson score
0 81 (40) 1476 (67) 7064 (79)
1 32 (16) 404 (18) 1083 (12)
≥2 89 (44) 314 (14) 782 (88)
Vaccinated* 80 (40) 641 (29) 2202 (25)
Race
White 12 (59) 364 (17) 1580 (18)
Black 5 (25) 93 (42) 324 (36)
Asian 1 (050) 24 (11) 81 (091)
Other 0 2 (<010) 9 (<010)
Unknown/missing 184 (91) 1711 (78) 6935 (78)
2004–2005 n = 204 n = 2614 n = 10 117
Age–Mean (SD) 69  14 54  17 52  16
Age–Median 72 54 51
BMI–Mean (SD) 29  642 9  632 8  57
BMI–Median 28 28 27
No. (%) No. (%) No. (%)
Normal weight 53 (26) 803 (31) 3487 (34)
Overweight 77 (38) 891 (34) 3625 (36)
Obese 74 (36) 920 (35) 3005 (30)
Female 120 (59) 1719 (66) 6313 (62)
Charlson score
0 77 (38) 1628 (62) 7686 (76)
1 45 (22) 564 (22) 1438 (14)
≥2 82 (40) 422 (16) 993 (98)
Vaccinated* 122 (60) 955 (37) 2663 (26)
Race
White 14 (69) 464 (18) 1919 (19)
Black 8 (39) 123 (47) 451 (45)
Asian 1 (049) 16 (061) 135 (13)
Other 0 2 (<010) 7 (<010)
Unknown/missing 181 (89) 2009 (77) 7605 (75)
2009 H1N1 n = 65 n = 1319 n = 6882
Age–Mean (SD) 57  11 46  15 47  13
Age–Median 57 48 49
BMI–Mean (SD) 30  692 9  632 8  59
BMI–Median 30 27 27
No. (%) No. (%) No. (%)
Normal weight 13 (20) 418 (32) 2310 (34)
Overweight 20 (31) 461 (35) 2471 (36)
Obese 32 (49) 440 (33) 2101 (31)
Female 32 (49) 885 (67) 4012 (58)
Charlson score
0 27 (42) 913 (69) 5441 (79)
Table 2. (Continued)
Severe ILI Mild ILI Controls
1 12 (18) 262 (20) 912 (13)
≥2 26 (40) 144 (11) 529 (78)
Vaccinated* 11 (169) 109 (83) 379 (55)
Race
White 32 (49) 634 (48) 3327 (48)
Black 11 (17) 155 (12) 749 (11)
Asian 0 38 (29) 232 (34)
Other 0 3 (023) 16 (023)
Unknown/missing 22 (34) 489 (37) 2558 (37)
BMI, body mass index; SD, standard deviation; EHR, electronic health
record.
Severe ILI includes only those hospitalized with ILI. This table contains
data for all three inﬂuenza seasons.
*Vaccine data were only available for those who received inﬂuenza
vaccine at an HVMA site (seasonal inﬂuenza vaccine transaction
recorded in electronic health record).
“Other” race contains American Indian/Alaskan Natives, Native
Hawaiian, or Other Paciﬁc Islander, and those with more than one
race reported.
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observedfor40-to59-year-olds(OR184,95%CI116,219).
Thereisnoevidenceofanassociationbetweenoverweightand
severe ILI in any of the three age groups. When we restricted
the age group analyses to those with a Charlson score of zero
(Table 6), the results were generally very similar.
Table 3. Crude and adjusted odds ratio (OR) and 95% conﬁdence intervals (95% CI) for severe and mild inﬂuenza-like illness (ILI) by season
Inﬂuenza season BMI category
Severe ILI Mild ILI
Crude OR Adjusted OR Crude OR Adjusted OR
2003–2004 Overweight 116 (082, 164) 088 (061, 126) 096 (086, 108) 099 (089, 112)
Obese 146 (103, 207) 114 (080, 164) 108 (096, 121) 106 (094, 119)
2004–2005 Overweight 140 (098, 199) 111 (077, 159) 107 (096, 119) 106 (095, 118)
Obese 162 (114, 231) 124 (086, 179) 133 (120, 148) 126 (113, 140)
2009 H1N1 Overweight 144 (071, 290) 109 (053, 224) 103 (089, 119) 117 (100, 135)
Obese 271 (142, 517) 176 (091, 342) 116 (100, 134) 122 (105, 142)
BMI, body mass index.
Severe ILI is a hospitalized ILI visit. Mild ILI is an outpatient ILI visit. Reference group is normal weight (BMI 185–249). Adjusted for sex, age
(continuous), and Charlson Comorbidity Index score (continuous).
Table 4. Crude and adjusted odds ratio (OR) and 95% conﬁdence intervals (95% CI) for severe and mild inﬂuenza-like illness (ILI) by season, among
those with a Charlson Comorbidity Index score of zero (0)
Inﬂuenza season BMI category
Severe ILI Mild ILI
Crude OR Adjusted OR Crude OR Adjusted OR
2003–2004 Overweight 112 (064, 197) 090 (051, 159) 092 (081, 105) 098 (085, 112)
Obese 191 (111, 327) 160 (093, 276) 101 (088, 116) 105 (091, 121)
2004–2005 Overweight 143 (082, 248) 112 (064, 197) 107 (094, 121) 109 (096, 125)
Obese 165 (093, 293) 143 (080, 256) 130 (114, 149) 133 (116, 152)
2009 H1N1 Overweight 181 (067, 491) 154 (056, 427) 098 (083, 116) 114 (096, 135)
Obese 226 (082, 623) 190 (068, 527) 109 (091, 129) 123 (103, 147)
BMI, body mass index.
Severe ILI is a hospitalized ILI visit. Mild ILI is an outpatient ILI visit. Reference group is normal weight (BMI 185–249); overweight = BMI 250–299;
obese = BMI ≥ 30. Adjusted for sex and age (continuous).
Table 5. Crude and adjusted odds ratio (OR) and 95% conﬁdence intervals (95% CI) for severe and mild inﬂuenza-like illness (ILI) by age group
Age group BMI category
Severe ILI Mild ILI
Crude OR Adjusted OR Crude OR Adjusted OR
20–39 years Overweight 130 (047, 358) 147 (052, 415) 105 (093, 120) 118 (104, 135)
Obese 233 (090, 606) 243 (091, 646) 121 (105, 138) 133 (116, 154)
40–59 years Overweight 104 (063, 172) 103 (062, 172) 103 (093, 114) 110 (098, 122)
Obese 205 (130, 323) 184 (116, 219) 131 (118, 146) 131 (117, 145)
≥60 years Overweight 098 (074, 130) 099 (075, 133) 095 (084, 108) 099 (087, 112)
Obese 104 (078, 138) 108 (080, 146) 103 (091, 118) 104 (091, 119)
BMI, body mass index.
Severe ILI is a hospitalized ILI visit. Mild ILI is an outpatient ILI visit. Reference group is normal weight (BMI 185–249); overweight = BMI 250–299;
obese = BMI ≥ 30. Adjusted for sex, age (continuous), and Charlson Comorbidity Index score (continuous).
Obesity as a risk factor for severe ILI
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race, among the small proportion of individuals with
complete race information in the dataset. For H1N1 (total
n = 5197; 43 severe ILI cases), after adjusting for race, sex,
age, and Charlson score, there was clear indication of an
association between obesity and severe ILI (OR 468, 95% CI
158, 1385) and between overweight and severe ILI (OR
307, 95% CI 099, 943). For the two regular seasons, there
were very few severe ILI cases among those with race
information (~20 per season) so the conﬁdence intervals
were very wide and the results difﬁcult to interpret.
Discussion
This study provides evidence of a small to moderate
association between obesity and hospitalized ILI, the size of
which appears to vary by inﬂuenza season and age group.
These results support previous ﬁndings of an association
between obesity and severe ILI identiﬁed during the H1N1
inﬂuenza A pandemic, but we also identiﬁed evidence of
obesity as an independent risk factor for hospitalized ILI
during non-pandemic inﬂuenza seasons. Importantly, when
restricted to individuals without comorbidities (i.e., a
Charlson Comorbidity Index score of zero), the association
was still apparent and the odds ratios were larger. Addition-
ally, our results suggest there may be a modest association
between obesity and outpatient ILI. The relation between
overweight and hospitalized ILI in this study is less clear and,
if present, may be small. While not all of the study results
reached statistical signiﬁcance, they suggest that obesity may
be an independent risk factor of severe ILI, particularly
among healthy, young adults, given the consistent, positive
direction of our ﬁndings.
For severe ILI, our results are comparable to, although
more modest than, those reported by Kwong et al.
11 Those
authors examined the association between self-reported BMI
and respiratory hospitalizations over 12 inﬂuenza seasons in
Ontario (n > 82 000). Among those without a risk factor for
inﬂuenza complications, those with a BMI of 30–349 had an
OR of 173 (95% CI 086, 346) compared with normal
weight individuals, and those with a BMI ≥ 35 had an OR of
510 (95% CI 253, 1024). When the authors stratiﬁed their
analyses by the number of risk factors, the ORs and
corresponding conﬁdence intervals were smaller. Another
group examined BMI and outpatient laboratory-conﬁrmed
inﬂuenza for two regular seasons (2007–2008 and 2008–
2009) and 2009 H1N1.
10 For 2009 H1N1, they reported small
increased odds of outpatient inﬂuenza among overweight
(OR 140, 95% CI 080, 245) and obese (BMI 30–399: OR
102, 95% CI 059, 178; BMI ≥ 40: OR 153, 95% CI 076,
308) compared with normal weight. The results for the two
non-pandemic periods are generally suggestive of a null
association.
The study described here contributes to a small but
growing literature on the relation between weight, and ILI
occurrence and outcome. Strengths of the study include the
large sample size and use of professionally ascertained weight
and height for BMI calculation rather than patient self-
reports. The robust EHR used by HVMA, and the practice’s
consistent use of practice-wide guidelines for situations such
as managing ILI during respiratory illness seasons allow for
conﬁdence in the stability of the dataset. The data quality is
good insofar as it is a paperless practice that has been using
EHRs for over 20 years. The EHR is used for all clinical
transactions and is therefore deeply engrained into routine
practice. The limitations of the dataset are those common to
all retrospective observational studies: The data are limited to
patients that opted to seek medical care and contingent upon
different clinician’s diagnostic, testing, and coding choices,
all of which were made primarily for the purposes of
Table 6. Crude and adjusted odds ratio (OR) and 95% conﬁdence intervals (95% CI) for severe and mild inﬂuenza-like illness (ILI) by age group,
among those with a Charlson Comorbidity Index score of zero (0)
Age group
BMI
category
Severe ILI Mild ILI
Crude OR Adjusted OR Crude OR Adjusted OR
20–39 years Overweight 076 (023, 251) 095 (028, 322) 102 (089, 117) 115 (099, 133)
Obese 194 (070, 535) 230 (082, 651) 121 (104, 140) 135 (116, 158)
40–59 years Overweight 158 (077, 321) 151 (073, 312) 103 (091, 116) 108 (095, 123)
Obese 267 (135, 528) 261 (131, 519) 122 (107, 138) 126 (111, 143)
≥60 years Overweight 099 (062, 159) 102 (063, 164) 098 (082, 116) 101 (085, 120)
Obese 114 (070, 188) 126 (076, 209) 106 (088, 128) 110 (091, 132)
BMI, body mass index.
Severe ILI is a hospitalized ILI visit. Mild ILI is an outpatient ILI visit. Reference group is normal weight (BMI 185–249); overweight = BMI 250–299;
obese = BMI ≥ 30. Adjusted for sex and age (continuous).
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To the extent that clinicians did assign diagnoses to patients,
however, the EHR is likely to be comprehensive. Because the
diagnosis codes for case determination were drawn from
patients’ insurance claims records, they include data from
encounters outside the primary study practice (e.g. specialty
referrals and hospitalizations). They are therefore likely to be
complete. It is also important to note that the cohorts were
restricted to individuals without a hospitalization in the prior
year, meaning that the study was among healthier individuals
than the larger patient population.
The study has several limitations. We examined ILI
derived from ICD-9 codes and were not able to examine
laboratory-conﬁrmed inﬂuenza. Our syndromic deﬁnition
captures respiratory illness due to multiple pathogens in
addition to inﬂuenza. We originally planned to restrict the
analysis to the periods within each season when inﬂuenza
activity was at its peak, but applying the ILI deﬁnition to a
small number of weeks per season yielded very few
hospitalized cases. While the HVMA EHR is a well-
established system, information gaps remain. Completeness
and accuracy of smoking status and inﬂuenza vaccine
exposure in the EHR were too unreliable to analyze. While
we do not believe these covariates are confounders, they may
be modiﬁers. For example, higher BMI has been associated
with less frequent inﬂuenza vaccination among the elderly.
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Data on race and ethnicity were missing for over 70% of
cases and controls in the regular inﬂuenza seasons and for
37% during 2009 H1N1. The proportion of individuals who
were overweight or obese may vary substantially by racial
group. Among those with documented race, 43% of Asians
were overweight or obese, 63% of Whites were overweight or
obese, 75% of those identiﬁed as “other” were overweight or
obese, and 83% of Blacks were overweight or obese. Among
those with missing race information, 67% were overweight
or obese. In a separate (unpublished) analysis of ILI in
Massachusetts, some of this study’s co-authors found
substantial disparities in rates of ILI hospitalization by race
during seasonal and pandemic years. We therefore have
concerns about potential residual confounding due to
missing race and ethnicity data, as well as other covariates
related to socioeconomic status. Our preliminary analysis for
H1N1, among those with race information, resulted in a
larger association for both obesity and overweight with
severe ILI, suggesting that race and ethnicity may be
important covariates. Additionally, the study was restricted
to those with a documented BMI. We have data available on
the frequency and characteristics of patients with missing
BMIs for the H1N1 study period, but unfortunately not for
the other seasons. For the H1N1 period, of the 35 099
individuals originally available for analysis, only 6%
(n = 2179) did not have BMI recorded within 12 months
of the study period start date (and were therefore excluded
from our full analysis). We compared those with and
without BMI recorded with respect to gender, age, and
Charlson score. Men were more likely to be missing BMI
than females (10% compared with 36%). The average age of
those with a measured BMI was 51 compared with an
average age of 43 for those without BMI. Seventy-ﬁve
percent of those with a recorded BMI had a Charlson score
of zero compared with 91% among those without a BMI
recorded. These differences, while important, are not
surprising as one may assume that males, younger adults,
and those without comorbidities would be less likely to have
annual medical visits. Finally, because the Charlson Comor-
bidity Index does not capture certain comorbidities associ-
ated with increased risk of severe inﬂuenza or other
respiratory infections (e.g., asthma not identiﬁed as chronic
lung disease), those with a score of zero may actually have an
underlying illness that put them at increased risk of severe
ILI. These comorbidities may also be associated with BMI, so
raise an additional concern about residual confounding.
Conclusions
Our study provides support for an association between
obesity and hospitalized ILI, varying by age group and
inﬂuenza season. A similar, but possibly smaller association,
may exist for obesity and outpatient ILI. These effects were
enhanced when limiting the analysis to patients without
known comorbidities, suggesting that even so-called
“healthy” overweight and obese adults may remain at
increased risk of ILI requiring hospitalization. Directions
for future research include larger studies that can capture
larger numbers of cases, studies designed to target subgroups
(e.g., younger ages), and studies designed to collect complete
and accurate data on covariates such as race, ethnicity,
comorbidities, and vaccination status.
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